<DOC>
	<DOC>NCT01684631</DOC>
	<brief_summary>The objective is to evaluate the implant survival rate for patients implanted with a PINNACLE® ULTAMET™ Metal-on-Metal implant for conventional total hip arthroplasty for the treatment of a severe hip disease and true femoral cervical fracture.</brief_summary>
	<brief_title>Evaluation of Implant Survival in Patients With a Pinnacle Ultamet Device in Conventional Total Hip Joint Replacement</brief_title>
	<detailed_description />
	<mesh_term>Joint Diseases</mesh_term>
	<criteria>Patients susceptible to receive a PINNACLE® ULTAMET™ implant as per routine practice Patient refusal to participate to the data collection Pregnant woman Patients age is less than 18 years old The planned intervention is a revision of a previous intervention on the studied hip joint Previous metal implant, except for pure titanium or titanium alloys Exposure to cobalt and chromium that could influence serum metal ions levels Planned bilateral intervention Patient residing outside France Patient not implanted with a Pinnacle(R) ULTAMET(TM)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>